56,465 results on '"GLOMERULONEPHRITIS"'
Search Results
2. NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)
3. A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
4. Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy
5. Affection of Renal and Urinary System in IBD Patients
6. Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
7. Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis (VALIANT)
8. C3G/Primary IC-MPGN EAP
9. Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
10. Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
11. Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3
12. A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial (RENATO)
13. A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease (RESULT)
14. Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
15. Effect of Ramadan Fasting on Kidney Function and Proteinuria in Patients With Glomerulonephritis
16. Rescue of Nephrons With ALE.F02 (RENAL-F02) (RENAL-F02)
17. Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
18. Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
19. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
20. Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
21. Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
22. Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases (ANTHEM)
23. An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis (VALE)
24. Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN (NOBLE)
25. Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) (RENAL AID)
26. Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE) (NewPLACE)
27. KidneYou - Innovative Digital Therapy
28. Immunoglobulin A nephropathy is not what it used to be!
29. 超声影像组学在肾炎组织学分型中的应用价值.
30. Clinicopathological characteristics of pediatric ANCA-associated glomerulonephritis.
31. Defining causes of death‐censored kidney allograft failure: A 5‐year multicentre ANZDATA and clinical cross‐sectional study.
32. Bibliometric and visual analysis of membranous nephropathy literature from 2010 to 2023.
33. Renal Manifestations of Chronic Hepatitis C: A Review.
34. ANCA‐Negative Pauci‐Immune Glomerulonephritis Associated with Bartonella Endocarditis.
35. Pathology of IgA nephropathy: A global perspective.
36. Current understanding and new insights in the treatment of IgA nephropathy.
37. 28/m mit Dyspnoe bei leichter Belastung: Vorbereitung auf die Facharztprüfung: Fall 19.
38. Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies.
39. Therapeutic targets in membranous nephropathy: plasma cells and complement.
40. Successful Treatment with Daratumumab of a Patient with Monoclonal Lambda Light Chain Disease Presenting as Nephrotic Syndrome and Crescentic Glomerulonephritis.
41. Preclinical Detection of Early Glomerular Injury in Children with Kidney Diseases—Independently of Usual Markers of Kidney Impairment and Inflammation.
42. Diagnostic accuracy of ANCA serology in ANCA‐associated vasculitis with renal involvement.
43. FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα–CPT1a pathway.
44. Effectiveness of intravenous methylprednisolone pulse in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis.
45. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
46. Pediatric contributions and lessons learned from the NEPTUNE cohort study.
47. A predictive mortality score in ANCA-associated renal vasculitis.
48. Haematuria and proteinuria in childhood.
49. The Etiology of Advanced Chronic Kidney Disease in Southeast Asia: A Meta-analysis.
50. Evaluation of Post-Infectious Glomerulonephritis: Single Center Experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.